December 13, 2025
Headlines

Expert Outlook: AbbVie Through The Eyes Of 4 Analysts

Sumain Faisal01 mins

Latest Ratings for ABBV

Date Firm Action From To
Feb 2022 UBS Downgrades Buy Neutral
Feb 2022 Mizuho Maintains Buy
Feb 2022 Barclays Maintains Equal-Weight

View More Analyst Ratings for ABBV

View the Latest Analyst Ratings

read more

Leave a Reply

Your email address will not be published. Required fields are marked *

Related News